Search clinical trials for: Rituximab-CHOP

Total 3491 results

Fudan University

Unknown

Thalidomide Combined With R-CHOP in Newly Diagnosed，Untreated Double-expressor Diffuse Large B-Cell Lymphoma Patients

Thalidomide

China
Kosin University Gospel Hospital

Completed

Erythropoietin for Management of Anemia Caused by Chemotherapy

Diffuse Large B-cell Lymphoma
Abbott Nutrition

Completed

Evaluation of Carbohydrates Part 2

Gastro-Intestinal Tolerance

Canada
AHS Cancer Control Alberta
Hoffmann-La Roche

Completed

FDG-PET-Stratified R-DICEP and R-Beam/ASCT For Diffuse Large B-Cell Lymphoma (PET-Chop)

Diffuse Large B Cell Lymphoma

Canada
The University of Tennessee, Knoxville

Completed

Carbohydrate-Protein Supplementation During Endurance Running

Supplementation During Endurance Performance

United States
Fudan University

Completed

Lenalidomide Combined With R-CHOP(R2-CHOP) in Newly Diagnosed Double-expressor Diffuse Large B-Cell Lymphoma Patients

Double Expressor Lymphoma

China
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Radiation Therapy and Rituximab in Treating Patients With Stage I-II Grade 1 or Grade 2 Follicular Lymphoma

Ann Arbor Stage I Grade 1 Follicular Lymphoma | Ann Arbor Stage I Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 1 Follicular Lymphoma | Ann Arbor Stage II Grade 2 Follicular Lymphoma

United States
National Cancer Institute (NCI)

Completed

Lenalidomide and Rituximab in Treating Patients With Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma

Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditions

United States
University of Toronto

Active, not recruiting

Comparison of Pulse Chips and Commercial Snacks on Food Intake, Appetite and Blood Glucose in Healthy Young Adults

Obesity | Diabetes

Canada
Shahid Beheshti University of Medical Sciences

Completed

The Effect of Hydrodynamic Parameters on Corneal Endothelial Cell Loss After Phacoemulsification

Cataract

Iran, Islamic Republic of
Weill Medical College of Cornell University
Bayer

Completed

Study of CHOP + Campath for T-Cell, Null Cell, or Natural Killer (NK)-Cell Lymphoma

T-Cell Lymphoma | Lymphoma, Non-Hodgkin's

United States
Pfizer

Completed

Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04)

Rheumatoid Arthritis

United States, Australia, Canada, Israel, Mexico, Colombia, Germany, Russian Federation, South Africa, United Kingdom
Thomas Morland

Not yet recruiting

Complete Health Improvement Program for Geisinger Health Plan Members With Type 2 Diabetes (CHIP-RCT)

Type 2 Diabetes
Mabion SA
Parexel

Withdrawn

MabionCD20® Compared to MabThera® and Rituxan® in Patients With Rheumatoid Arthritis (MABRIDGE)

Rheumatoid Arthritis
First Affiliated Hospital of Wenzhou Medical University

Recruiting

The Efficacy and Safety of ZR2 Versus R-CHOP-like Regimen for Elderly Patients With Newly Diagnosed Diffuse Large B Cell Lymphoma.

Diffuse Large B Cell Lymphoma

China
Zhejiang Cancer Hospital

Recruiting

ZR2 Followed by Immunochemotherapy in Elderly Patients With Newly-diagnosed DLBCL

Diffuse Large B Cell Lymphoma

China
The Catholic University of Korea

Active, not recruiting

Interim FDG PET/CT in Diffuse Large B Cell Lymphoma (DLBCL) Patients

Lymphoma, Large B-Cell, Diffuse

Korea, Republic of
McMaster University
Canadian Institutes of Health Research (CIHR); Hamilton Academic Health Sciences...

Completed

A Community Paramedicine Initiative for Older Adults Living in Subsidized Housing (CHAP-EMS/CP@Clinic) (CHAP-EMS)

Cardiovascular Diseases | Diabetes Mellitus

Canada
National Cancer Institute (NCI)

Active, not recruiting

Alisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or B-cell Low Grade Non-Hodgkin Lymphoma

Recurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma

United States
Abbott Nutrition

Not yet recruiting

Benefits of Nutritional Ingredients for Type 2 Diabetes

Diabetes type2

United States
Washington University School of Medicine

Recruiting

Polatuzumab Vedotin (Pola) Plus Rituximab (R) in Patients With Post-transplant Lymphoproliferative Disorder (PTLD)

Post-transplant Lymphoproliferative Disorder

United States
DEKK-TEC, Inc.

Completed

DM-CHOC-PEN for Brain Tumors in AYA Subjects

Advanced Cancer | Brain Metastases

United States
Taipei Medical University

Unknown

Effects of Work Shop for Children With Developmental Delays

Developmental Delays

Taiwan
French Innovative Leukemia Organisation

Completed

Treatment of Localized Low Grade Lymphomas

Lymphoma, Low-Grade

France
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

A Randomized, Open-label, Multi-center, Phase III Study of Orelabrutinib in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) vs. R-CHOP Alone in Patients With Treatment-naїve Mantle Cell Lymphoma

Treatment-naїve Mantle Cell Lymphoma

China
Lymphoma Study Association

Completed

Mini-CHOP and Rituximab in Patients Aged Over 80 Years

Diffuse Large B-Cell Lymphoma
The First Affiliated Hospital of Soochow University

Unknown

Chidamide With CHOP Regimen for de Novo PTCL Patients (CHOP: Cyclophosphamide, Etoposide, Vincristine and Prednisone; PTCL: Peripheral T Cell Lymphoma) (CHOP)

Peripheral T Cell Lymphoma

China
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Active, not recruiting

Ibrutinib With or Without Rituximab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia

Recurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Recurrent Chronic Lymphocytic Leukemia

United States
Erica Goldstein

Completed

Effect of Carbohydrate-protein Co-ingestion on Short-term Recovery

Dietary Supplementations

United States
RTI International
Durham County Department of Public Health; Guilford County Department of Public... and other collaborators

Terminated

NC Young Women's CoOp

Human Immunodeficiency Virus (HIV) | Condomless Sex | Alcohol and Drug Use | Sexually Transmitted Infection (STI)

United States
Regina Elena Cancer Institute
University of Rome Tor Vergata; Campus Bio-Medico University; Sant'Eugenio Hospital...

Recruiting

Transcriptomics and Epigenetics Analysis in Drug-Resistance of Multiple Myeloma (TEDROMM)

Multiple Myeloma

Italy
University of Michigan
Emory University; University of California, San Francisco; Research Foundation...

Completed

A Couples-based Intervention for Transgender Women and Their Partners (T2)

HIV Infections | HIV Primary Infection

United States
Philip Morris Products S.A.

Completed

Reduced Exposure Study Using CHTP 1.0 During 5 Days in Confinement.

Smoking

Poland
DEKK-TEC, Inc.
National Cancer Institute (NCI)

Completed

Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer (DM-CHOC-PEN)

Advanced Cancer | Brain Involvement

United States
DEKK-TEC, Inc.
National Cancer Institute (NCI)

Completed

Study of 4-Demethylcholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in Patients With Advanced Cancer" (DM-CHOC-PEN)

Advanced Cancer

United States
Peking University

Recruiting

Linperlisib-based Treatment Regimen in Newly Diagnosed Nodal T-follicular Helper Cell Lymphoma (nTFHL)

Nodal T-follicular Helper Cell Lymphoma

China
Fondazione Italiana Linfomi - ETS

Active, not recruiting

Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell

Lymphoma | Large B-Cell | Diffuse Large B-Cell

Italy
National Cancer Institute (NCI)
Celgene Corporation

Active, not recruiting

Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Follicular Lymphoma

Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma | Ann Arbor Stage II Grade 3 Non-Contiguous... and other conditions

United States
Dana-Farber Cancer Institute
Genentech, Inc.

Recruiting

A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R or R-CHOP for Patients With Richter's Syndrome

Richter Syndrome

United States
Amgen

Completed

STAAR-3 Clinical Study

Chronic Kidney Disease | Chronic Renal Insufficiency | Kidney Disease | Pre-dialysis | Pre-ESRD
Amgen

Completed

Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy

Cancer | Non-Myeloid Malignancies
Alaunos Therapeutics

Withdrawn

Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma

Lymphoma
Heart and Diabetes Center North-Rhine Westfalia

Completed

Macronutrient Relations and Weight Loss in Obese Subjects

Obesity

Germany
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Zanubrutinib and Rituximab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

United States
The Affiliated Hospital of Qingdao University

Not yet recruiting

Population Pharmacokinetic-pharmacodynamic Study of Rituximab in Children With Blood Diseases

Children | Blood Disease | Rituximab
University of Connecticut

Completed

Adapting a Behavioral Intervention to Accommodate Cognitive Dysfunction in People Who Inject Drugs

Cognitive Dysfunction

United States
M.D. Anderson Cancer Center

Recruiting

ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma

Refractory Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Richter Syndrome | Refractory Mantle Cell Lymphoma | Refractory Aggressive B-Cell Non-Hodgkin Lymphoma | Refractory High Grade B-Cell Lymphoma | Refractory Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma | Refractory... and other conditions

United States
First Affiliated Hospital of Zhejiang University

Unknown

Chidamide With R-CHOP Regimen for DLBCL Patients (DLBCL)

Diffuse Large B Cell Lymphoma

China
University Hospital, Toulouse

Completed

Study of the Influence of Plasma Exchange on the Pharmacokinetics of Rituximab (PK-rituximab)

Autoimmune Diseases | Renal Transplant

France
Sunnybrook Health Sciences Centre
Queen's University; The Leukemia and Lymphoma Society

Recruiting

Clonal Hematopoiesis is a Risk Factor for Chemotherapy-Related Complications

Lymphoma | Chemotherapeutic Toxicity

Canada

Search clinical trials for: Rituximab-CHOP

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Paraguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations